Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB01259"

Predicate	Value (sorted: none)
drugbank:interactsWith	drug:Voriconazole
drugbank:interactsWith	drug:Artemether
drugbank:interactsWith	drug:Toremifene
owl:sameAs	drug:Vorinostat
owl:sameAs	drug:Tretinoin
owl:sameAs	drug:Pazopanib
owl:sameAs	drug:Tacrolimus
owl:sameAs	drug:Zuclopenthixol decanoate
drugbank:drugCategory	drugcategory:Protein Kinase Inhibitors
drugbank:interactsWith	drug:Etravirine
drugbank:interactsWith	drug:Zuclopenthixol decanoate
drugbank:interactsWith	drug:Tolterodine
drugbank:interactsWith	drug:Trazodone
drugbank:interactsWith	drug:Tacrolimus
owl:sameAs	drug:Trimipramine
drugbank:interactsWith	drug:Tretinoin
drugbank:interactsWith	drug:Zuclopenthixol
owl:sameAs	drug:Artemether
rdf:type	drugbank:drugs
owl:sameAs	drug:Thiothixene
drugbank:interactsWith	drug:Ziprasidone
drugbank:interactsWith	drug:Telithromycin
drugbank:interactsWith	drug:Tamsulosin
owl:sameAs	drug:Zuclopenthixol
owl:sameAs	drug:Etravirine
owl:sameAs	drug:Tramadol
owl:sameAs	drug:Telithromycin
owl:sameAs	drug:Ziprasidone
owl:sameAs	drug:Toremifene
owl:sameAs	drug:Lumefantrine
owl:sameAs	drug:Tamsulosin
drugbank:interactsWith	drug:Lumefantrine
owl:sameAs	drug:Topotecan
drugbank:interactsWith	drug:Thiothixene
owl:sameAs	drug:DB02584
drugbank:interactsWith	drug:Zuclopenthixol acetate
drugbank:interactsWith	drug:Vorinostat
drugbank:interactsWith	drug:Tramadol
rdfs:label	"Lapatinib"
owl:sameAs	drug:Tolterodine
owl:sameAs	drug:Voriconazole
owl:sameAs	drug:Trazodone
owl:sameAs	drug:Zuclopenthixol acetate
drugbank:interactsWith	drug:Pazopanib
drugbank:interactsWith	drug:Topotecan
drugbank:interactsWith	drug:Trimipramine
drugbank:drugCategory	drugcategory:Antineoplastic Agents
drugbank:description	"Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding."

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource appears as object in 42 triples

Context graph